217 related articles for article (PubMed ID: 25960134)
1. Phenotype-dependent alteration of pathways and networks reveals a pure synergistic mechanism for compounds treating mouse cerebral ischemia.
Wang PQ; Li B; Liu J; Zhang YY; Yu YN; Zhang XX; Yuan Y; Guo ZL; Wu HL; Li HX; Dang HX; Guo SS; Wang Z
Acta Pharmacol Sin; 2015 Jun; 36(6):734-47. PubMed ID: 25960134
[TBL] [Abstract][Full Text] [Related]
2. Pure mechanistic analysis of additive neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice.
Wang PQ; Liu Q; Xu WJ; Yu YN; Zhang YY; Li B; Liu J; Wang Z
Acta Pharmacol Sin; 2018 Jun; 39(6):961-974. PubMed ID: 29345255
[TBL] [Abstract][Full Text] [Related]
3. Jasminoidin and ursodeoxycholic acid exert synergistic effect against cerebral ischemia-reperfusion injury via Dectin-1-induced NF-κB activation pathway.
Hao DL; Xie R; Zhong YL; Li JM; Zhao QH; Huo HR; Xiong XJ; Sui F; Wang PQ
Phytomedicine; 2023 Jul; 115():154817. PubMed ID: 37121061
[TBL] [Abstract][Full Text] [Related]
4. Divergence and Convergence of Cerebral Ischemia Pathways Profile Deciphers Differential Pure Additive and Synergistic Mechanisms.
Wei P; Wang P; Li B; Gu H; Liu J; Wang Z
Front Pharmacol; 2020; 11():80. PubMed ID: 32161541
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
[TBL] [Abstract][Full Text] [Related]
6. Genome Analysis Reveals a Synergistic Mechanism of Ursodeoxycholic Acid and Jasminoidin in Mice Brain Repair After Ischemia/Reperfusion: Crosstalk Among Muti-Pathways.
Zhang Y; Li H; Guo H; Li B; Zhao Z; Wang P; Wu H; Liu J; Chen Y; Zhang X; Wu P; Wang Z; Wang J
Front Pharmacol; 2019; 10():1383. PubMed ID: 31920636
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.
Yang ZZ; Liu W; Zhang F; Li Z; Cheng YY
Acta Pharmacol Sin; 2015 Jun; 36(6):699-707. PubMed ID: 25960133
[TBL] [Abstract][Full Text] [Related]
8. Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy.
Zhao N; Li J; Li L; Niu XY; Jiang M; He XJ; Bian ZX; Zhang G; Lu AP
Acta Pharmacol Sin; 2015 Jun; 36(6):716-23. PubMed ID: 25948477
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical profiles of signaling pathways and networks reveal two complementary pharmacological mechanisms.
Chen Y; Meng F; Fang H; Yu Y; Liu J; Jing Z; Lv A; Wang Z; Wang Y
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):882-93. PubMed ID: 23469837
[TBL] [Abstract][Full Text] [Related]
10. Outcome-dependent global similarity analysis of imbalanced core signaling pathways in ischemic mouse hippocampus.
Liu J; Zhang ZJ; Zhou CX; Wang Y; Cheng YY; Duan DY; Wang YY; Wang Z
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1070-82. PubMed ID: 22998140
[TBL] [Abstract][Full Text] [Related]
11. Variations in target gene expression and pathway profiles in the mouse hippocampus following treatment with different effective compounds for ischemia-reperfusion injury.
Chen Y; Zhou C; Yu Y; Liu J; Jing Z; Lv A; Meng F; Wang Z; Wang Y
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):797-806. PubMed ID: 22622953
[TBL] [Abstract][Full Text] [Related]
12. Fusion of core pathways reveals a horizontal synergistic mechanism underlying combination therapy.
Wang Z; Jing ZW; Zhou CX; Zhang L; Cheng J; Zhang ZJ; Liu J; Xu CS; Li PT; Wang YY
Eur J Pharmacol; 2011 Sep; 667(1-3):278-86. PubMed ID: 21658381
[TBL] [Abstract][Full Text] [Related]
13. Poly-dimensional network comparative analysis reveals the pure pharmacological mechanism of baicalin in the targeted network of mouse cerebral ischemia.
Liu Q; Liu J; Wang P; Zhang Y; Li B; Yu Y; Dang H; Li H; Zhang X; Wang Z
Brain Res; 2017 Jul; 1666():70-79. PubMed ID: 28465229
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression Profiling Confirms the Dosage-Dependent Additive Neuroprotective Effects of Jasminoidin in a Mouse Model of Ischemia-Reperfusion Injury.
Li H; Wang J; Wang P; Zhang Y; Liu J; Yu Y; Li B; Wang Z
Biomed Res Int; 2018; 2018():2785636. PubMed ID: 29862259
[TBL] [Abstract][Full Text] [Related]
15. A partial pathway- and network-based transformation reveals the synergistic mechanism of JA and UA against cerebral ischemia-reperfusion injury.
Guo S; Guo L; Yu Y; Li B; Zhang Y; Li H; Wu P; Wang J; Yuan Y; Wang Z; Wang Y
Protein Cell; 2014 Nov; 5(11):873-7. PubMed ID: 25217044
[No Abstract] [Full Text] [Related]
16. [Similarity and diversity analysis of qingkailing effective components in regulating hippocampus ischemia-related genes of mice].
Zhou C; Wang Z; Zhang Z; Jing Z
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2475-9. PubMed ID: 21141504
[TBL] [Abstract][Full Text] [Related]
17. Vertical and Horizontal Convergences of Targeting Pathways in Combination Therapy with Baicalin and Jasminoidin for Cerebral Ischemia.
Li B; Yu Y; Zhang Y; Liu J; Li H; Dang H; Guo S; Wang L; Wu H; Wang Z; Wang Y
CNS Neurol Disord Drug Targets; 2016; 15(6):740-50. PubMed ID: 26996167
[TBL] [Abstract][Full Text] [Related]
18. Synergistic mechanism of gene expression and pathways between jasminoidin and ursodeoxycholic acid in treating focal cerebral ischemia-reperfusion injury.
Liu J; Zhou CX; Zhang ZJ; Wang LY; Jing ZW; Wang Z
CNS Neurosci Ther; 2012 Aug; 18(8):674-82. PubMed ID: 22726253
[TBL] [Abstract][Full Text] [Related]
19. Diverse array-designed modes of combination therapies in Fangjiomics.
Liu J; Wang Z
Acta Pharmacol Sin; 2015 Jun; 36(6):680-8. PubMed ID: 25864646
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the network structural characteristics of calcium signaling pathway in cerebral ischemia after intervention by different components of Chinese medicine.
Jing ZW; Yan ZL; Zhou CX; Wang LY; Liu J; Wu HL; Zhang ZJ; Li M; Li PT; Zhou J; Wang Z
J Tradit Chin Med; 2011 Sep; 31(3):251-5. PubMed ID: 21977872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
